Search filters

List of works by Evanthia Galanis

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

scientific article published on 27 April 2006

A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872

scientific article published on 10 July 2019

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K

scientific article

Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts

scientific article published on November 1, 2010

Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas

scientific article

Aurora-A Kinase as a Promising Therapeutic Target in Cancer

scientific article

Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERα expression in initially ERα+ breast cancer cells

scientific article

Aurora-A overexpression is linked to development of aggressive teratomas derived from humans iPS cells

scientific article

Barriers to Accrual and Enrollment in Brain Tumor Trials

scientific article published on 07 June 2019

Biodistribution of Oncolytic Measles Virus After Intraperitoneal Administration into Ifnar™-CD46Ge Transgenic Mice

scientific article published on November 1, 2003

Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice

scientific article

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination

scientific article

Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group

scientific article

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

scientific article published on 22 February 2017

Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview

scientific article published on February 2009

Clinical trial end points for high-grade glioma: the evolving landscape.

scientific article published on 09 February 2011

Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress

scientific article published on February 2007

Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme

scientific article published on December 2007

Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials

scientific article (publication date: September 2015)

Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy

scientific article

Converting tumor-specific markers into reporters of oncolytic virus infection

scientific article

Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model

scientific article

Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm

scientific article

Development of monoclonal antibody-based immunoassays for detection of Helicobacter pylori neutrophil-activating protein

scientific article published on June 28, 2012

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial

scientific article published on July 2016

Effective Radiovirotherapy for Malignant Gliomas by Using Oncolytic Measles Virus Strains Encoding the Sodium Iodide Symporter (MV-NIS)

scientific article published on March 9, 2012

Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma.

scientific article

Engineered measles virus as a novel oncolytic therapy against prostate cancer

scientific article published on January 2009

Enzastaurin in the treatment of recurrent glioblastoma: a promise that did not materialize

scientific article published in February 2010

Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas

scientific article published on 13 February 2007

Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus

scientific article

Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy

scientific article

Glioblastoma

scientific article published on January 2016

High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system

scientific article

INNV-13. ALLELE: A CONSORTIUM FOR PROSPECTIVE GENOMICS AND FUNCTIONAL DIAGNOSTICS TO GUIDE PATIENT CARE AND TRIAL ANALYSIS IN NEWLY-DIAGNOSED GLIOBLASTOMA

Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel

scientific article published in March 2007

Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein

scientific article published on December 21, 2010

Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment

scientific article published on 23 September 2016

Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments

scientific article published on February 1, 2011

Incorporation of prognostic and predictive factors into glioma clinical trials

scientific article published on February 2013

Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma

scientific article published on 27 March 2019

Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.

scientific article published on 27 February 2013

Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.

scientific article

Interferon signaling predicts response to oncolytic virotherapy

Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity

scientific article published on 29 July 2008

Intraperitoneal therapy of ovarian cancer using an engineered measles virus.

scientific article published in August 2002

Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma

scientific article published on December 2004

Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

scientific article published on 7 September 2017

It Is Time to Include Patients With Brain Tumors in Phase I Trials in Oncology

scientific article published on July 18, 2011

Leptomeningeal metastases of solid cancer.

scientific article published on 22 September 2016

Measles virus expressed Helicobacter pylori neutrophil-activating protein significantly enhances the immunogenicity of poor immunogens

scientific article published on August 12, 2013

Medical management of high-grade astrocytoma: current and emerging therapies.

scientific article

Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model

scientific article

MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors

scientific article published on 28 July 2016

Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells

scientific article published in September 2017

NI-36VALIDATION OF RANO CRITERIA: CONTRIBUTION OF T2/FLAIR ASSESSMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED WITH BEVACIZUMAB.

scientific article published in November 2014

Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells

scientific article published on December 21, 2012

New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials

scientific article published on 18 September 2013

Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter

scientific article

North Central Cancer Treatment Group Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination With Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme

scientific article published on September 23, 2010

Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer

scientific article

Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma

scientific article published on 3 February 2012

Oncolytic measles virus retargeting by ligand display

scientific article published on January 2012

Oncolytic measles virus strains as novel anticancer agents

scientific article published on 06 January 2013

Oncolytic measles virus strains in the treatment of gliomas

scientific article published on 01 February 2008

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients

scientific article published on 24 January 2020

Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer

scientific article published on 24 January 2013

PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel

scientific article published on June 2008

Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme

scientific article published on April 2005

Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.

scientific article published on 3 January 2018

Phase 2 trial design in neuro-oncology revisited: a report from the RANO group

scientific article published on May 2012

Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors

scientific article published on 8 September 2003

Phase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomas

scientific article

Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer

scientific article published on 18 March 2008

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

scientific article

Phase I/II Trial of Vorinostat Combined with Temozolomide and Radiation Therapy for Newly Diagnosed Glioblastoma: Final Results of Alliance N0874/ABTC 02.

scientific article published on 22 August 2017

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial.

scientific article published in October 2005

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM

scientific article

Phase II Study of Bevacizumab in Combination with Sorafenib in Recurrent Glioblastoma (N0776): A North Central Cancer Treatment Group Trial

scientific article published on 05 July 2013

Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

scientific article published on April 15, 2003

Phase II trial of gemcitabine in advanced sarcomas

scientific article

Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma

scientific article

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study

scientific article published on 5 July 2005

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

scientific article

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

scientific article published on November 16, 2011

Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study

scientific article

Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute

scientific article published on 25 February 2012

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

scientific article

Potential and clinical translation of oncolytic measles viruses

scientific article published on 27 January 2017

Proposed Response Assessment and Endpoints for Meningioma Clinical Trials: Report from the Response Assessment in Neuro-Oncology (RANO) Working Group

scientific article published on 01 January 2019

Quantification of the impact of enzyme-inducing antiepileptic drugs on irinotecan pharmacokinetics and SN-38 exposure

scientific article

Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline

scientific article

Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations

scientific article published on 30 May 2017

Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells

scientific article published on March 19, 2012

Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates

scientific article published on November 2006

Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report

scientific article published on 27 April 2018

Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples

scientific article

Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity

scientific article published on December 2006

Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology

scientific article published on September 2009

Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13.

scientific article published on April 2012

Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial

scientific article published on 5 August 2017

Tailoring chemotherapy for low-grade gliomas

scientific article published in December 2014

Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations

scientific article published on 17 July 2019

Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion

scientific article published on February 14, 2013

Targeting angiogenesis: progress with anti-VEGF treatment with large molecules

scientific article published on 28 July 2009

Technology evaluation: Allovectin-7, Vical

scientific article

The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab

scientific article published on 21 October 2015

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

scientific article published in May 2017

Toxicology study of repeat intracerebral administration of a measles virus derivative producing carcinoembryonic antigen in rhesus macaques in support of a phase I/II clinical trial for patients with recurrent gliomas

scientific article

Translational Research in Oncolytic Measles Virotherapy: Early Discoveries And Future Steps

scientific article published on February 1, 2011

Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine

scientific article

Treatment of medulloblastoma with a modified measles virus

scientific article

Tumour-fighting virus homes in

scientific article published on August 31, 2011

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

scientific article published on 15 March 2010

Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods

scientific article published on 2 March 2006

Validation of post-operative residual contrast enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma

scientific article published on 5 April 2018

Vertebra plana caused by primary Ewing sarcoma: case report and review of the literature

scientific article

Vorinostat in solid and hematologic malignancies

scientific article

What next for newly diagnosed glioblastoma?

scientific article

Where size matters: imaging-based biomarkers for patient stratification

scientific article published in January 2017